Arctic Bioscience AS (DE:9TD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Arctic Bioscience’s CSO, Hogne Hallaråker, recently purchased 5,000 shares in the company, adding to his existing holdings through Gold Coast Nutrition, which owns 460,000 shares. The company, known for its pharmaceutical products and dietary supplements derived from marine materials, is advancing a new drug candidate for psoriasis treatment. This move reflects confidence in the company’s innovative pipeline and market potential.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
